EXELIXIS, INC.
Patent Owner
Stats
- 56 US PATENTS IN FORCE
- 11 US APPLICATIONS PENDING
- Feb 08, 2018 most recent publication
Details
- 56 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 3,906 Total Citation Count
- May 26, 1998 Earliest Filing
- 199 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0037,552 Malate salt of N-(4-phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancerJun 09, 17Feb 08, 18[C07D]
2018/0002,289 Malate salt of N-(4-phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancerJun 08, 17Jan 04, 18[C07D]
2017/0275,251 Malate salt of N-(4-phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancerJun 13, 17Sep 28, 17[C07D]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9809549 Malate salt of N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancerJul 25, 14Nov 07, 17[C07D]
9717720 Processes for preparing quinoline compounds and pharmaceutical compositions containing such compoundsFeb 10, 12Aug 01, 17[A61K, C07D]
9011863 Combinations of kinase inhibitors for the treatment of cancerJul 08, 11Apr 21, 15[A61K, A01N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0378,436 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their use and ManufactureAbandonedNov 23, 11Dec 25, 14[C07D]
2014/0302,012 Combination Therapies for Treating Hematologic Malignancies Using Pyridopyrimidinone Inhibitors of PI3K/mTOR with Bendamustine and/or RituximabAbandonedJun 15, 12Oct 09, 14[A61K]
2014/0303,172 Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Lymphoproliferative MalignanciesAbandonedNov 01, 12Oct 09, 14[C07D]
2014/0296,265 Method of Treating Lymphoma Using Pyridopyrimidinone Inhibitors of PI3K/mTORAbandonedApr 27, 12Oct 02, 14[C07D]
2014/0275,527 Azetidines as MEK Inhibitors for the Treatment of Proliferative DiseasesAbandonedJun 27, 13Sep 18, 14[C07D]
2014/0107,100 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and ManufactureAbandonedNov 23, 11Apr 17, 14[C07D]
2014/0080,810 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and ManufactureAbandonedNov 15, 11Mar 20, 14[A61K, C12Q, C07D, G01N]
2014/0066,431 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and ManufactureAbandonedNov 15, 11Mar 06, 14[A61K, C12Q, G01N]
8648066 Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufactureExpiredMay 20, 10Feb 11, 14[A61K, C07D, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.